Aclidinium Bromide/Formoterol Fumarate 400/12μg BID

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Pulmonary Disease, Chronic Obstructive

Drug Information

Target Indication

Pulmonary Disease, Chronic Obstructive

Clinical Trial

Last updated: 4/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

AZNCF

ASTRAZENECA PLC

Related Pipeline

Anxiety Disorders

Healthy Japanese Children Age 2 Years Through 6 Years

Generalized Anxiety Disorder

Metastatic Castration-resistant Prostate Cancer

Triple Negative Breast Neoplasms

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts